Properties of Immature Myeloid Progenitors with Nitric-Oxide-Dependent Immunosuppressive Activity Isolated from Bone Marrow of Tumor-Free Mice

por Forghani, Parvin, Harris, Wayne, Giver, Cynthia R., Mirshafiey, Abbas, Galipeau, Jacques, Waller, Edmund K.
Publicado 2013

Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation

por Darlak, Katarzyna A, Wang, Ying, Li, Jian-Ming, Harris, Wayne AC, Giver, Cynthia R, Huang, Chunzi, Waller, Edmund K
Publicado 2014

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy

por Olsen, T. Anders, Zhuang, Tony Zibo, Caulfield, Sarah, Martini, Dylan J., Brown, Jacqueline T., Carthon, Bradley C., Kucuk, Omer, Harris, Wayne, Bilen, Mehmet Asim, Nazha, Bassel
Publicado 2022

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials

por Zhuang, Tony Zibo, Case, Katherine, Olsen, Timothy Anders, Brown, Jacqueline T., Carthon, Bradley C., Kucuk, Omer, Goldman, Jamie, Harris, Wayne, Bilen, Mehmet Asim, Nazha, Bassel
Publicado 2022

Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy

por Cross, Brian W., Johnson, Timothy V., DeRosa, Austin B., Ogan, Kenneth, Pattaras, John G., Nieh, Peter T., Kucuk, Omer, Harris, Wayne B., Master, Viraj A.
Publicado 2012

External validation of the modified Glasgow prognostic score for renal cancer

por Tai, Caroline G., Johnson, Timothy V., Abbasi, Ammara, Herrell, Lindsey, Harris, Wayne B., Kucuk, Omer, Canter, Daniel J., Ogan, Kenneth, Pattaras, John G., Nieh, Peter T., Master, Viraj A.
Publicado 2014

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism

por Yang, Hua, Brackett, Craig M., Morales-Tirado, Vanessa Marie, Li, Zezhong, Zhang, Qing, Wilson, Matthew W., Benjamin, Camille, Harris, Wayne, Waller, Edmund K., Gudkov, Andrei V., Burdelya, Lyudmila G., Grossniklaus, Hans E.
Publicado 2015

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

por Martini, Dylan J., Liu, Yuan, Shabto, Julie M., Carthon, Bradley C., Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Publicado 2019

A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma

por Sekar, Rishi R., Patil, Dattatraya, Baum, Yoram, Pearl, Jeffrey, Bausum, Anna, Bilen, Mehmet A., Kucuk, Omer, Harris, Wayne B., Carthon, Bradley C., Alemozaffar, Mehrdad, Filson, Christopher P., Pattaras, John G., Nieh, Peter T., Ogan, Kenneth, Master, Viraj A.
Publicado 2017

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

por Shabto, Julie M., Martini, Dylan J., Liu, Yuan, Ravindranathan, Deepak, Brown, Jacqueline, Hitron, Emilie E., Russler, Greta A., Caulfield, Sarah, Kissick, Haydn, Alemozaffar, Mehrdad, Ogan, Kenneth, Harris, Wayne B., Master, Viraj A., Kucuk, Omer, Carthon, Bradley C., Bilen, Mehmet A.
Publicado 2020

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

por Olsen, T. Anders, Martini, Dylan J., Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Nazha, Bassel, Bilen, Mehmet Asim
Publicado 2021

Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity

por Napier, Ruth J., Norris, Brian A., Swimm, Alyson, Giver, Cynthia R., Harris, Wayne A. C., Laval, Julie, Napier, Brooke A., Patel, Gopi, Crump, Ryan, Peng, Zhenghong, Bornmann, William, Pulendran, Bali, Buller, R. Mark, Weiss, David S., Tirouvanziam, Rabindra, Waller, Edmund K., Kalman, Daniel
Publicado 2015

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

por Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Nazha, Bassel, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Bilen, Mehmet Asim
Publicado 2021

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

por Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Hitron, Emilie Elise, Russler, Greta Anne, Yantorni, Lauren, Caulfield, Sarah, Brown, Jacqueline T., Goldman, Jamie M., Nazha, Bassel, Carthon, Bradley C., Harris, Wayne B., Kucuk, Omer, Master, Viraj A, Bilen, Mehmet Asim
Publicado 2022

Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases

por Tan, Shanshan, Yang, Hua, Xue, Shenghui, Qiao, Jingjuan, Salarian, Mani, Hekmatyar, Khan, Meng, Yuguang, Mukkavilli, Rao, Pu, Fan, Odubade, Oluwatosin Y., Harris, Wayne, Hai, Yan, Yushak, Melinda L., Morales-Tirado, Vanessa M., Mittal, Pardeep, Sun, Phillip Z., Lawson, David, Grossniklaus, Hans E., Yang, Jenny J.
Publicado 2020

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

por Brown, Jacqueline T, Liu, Yuan, Shabto, Julie M, Martini, Dylan, Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren, Joshi, Shreyas Subhash, Kissick, Haydn, Ogan, Kenneth, Nazha, Bassel, Carthon, Bradley C, Kucuk, Omer, Harris, Wayne B, Master, Viraj A, Bilen, Mehmet Asim
Publicado 2021

Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma

por Harvey, R. Donald, Carthon, Bradley C., Lewis, Colleen, Hossain, Mohammad S., Zhang, Chao, Chen, Zhengjia, Harris, Wayne B., Alese, Olatunji B., Shaib, Walid, Bilen, Mehmet A., Lawson, David H., Wu, Christina, Steuer, Conor E., El-Rayes, Bassel F., Khuri, Fadlo R., Lonial, Sagar, Waller, Edmund K., Ramalingam, Suresh S., Owonikoko, Taofeek K.
Publicado 2020